Skip to main content
SpringerLink
Log in

Metabolic hypertension: concept and practice

  • Review
  • Published:
Frontiers of Medicine Aims and scope Submit manuscript

Abstract

Hypertension is a serious public health problem worldwide. More than 60% of the risk factors for hypertension are associated with metabolic disturbances. Metabolic abnormalities increase the risk for hypertension and cause high blood pressure. Improving metabolic disturbances is beneficial for hypertension treatment. Due to the importance of metabolic abnormalities in the pathogenesis of hypertension, we propose a concept of metabolic hypertension. In this review, we discuss and review the clinical types, pathogenesis, risk evaluation and management of metabolic hypertension. Elucidation of the mechanism of metabolic hypertension should facilitate the design of novel pharmacotherapeutics and dedicated antihypertensive manipulations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lee SR, Cha MJ, Kang DY, Oh KC, Shin DH, Lee HY. Increased prevalence of metabolic syndrome among hypertensive population Ten years’ trend of the Korean National Health and Nutrition Examination Survey. Int J Cardiol 2011 Dec 20. [Epub ahead of print] doi: 10-1016/j.ijcard.2011.11.095

    Google Scholar 

  2. Pool PE. The case for metabolic hypertension: is it time to restructure the hypertension paradigm? Prog Cardiovasc Dis 1993; 36(1): 1–38

    Article  PubMed  CAS  Google Scholar 

  3. Zhu ZM. Metabolic hypertension. In: Zhu ZM. Metabolic syndrome: pathogenesis and clinical practice. Beijing: People’s Military Medical Press, 2005: 275–294 (in Chinese)

    Google Scholar 

  4. Zhu ZM. Metabolic hypertension: an issue worth exploring. Chin J Hypertens (Zhonghua Gao Xue Ya Za Zhi) 2006; 14(11): 859–860 (in Chinese)

    Google Scholar 

  5. Zhu ZM. Metabolic syndrome: an obesity-related metabolic cardiovascular syndrome. Chin J Endocrino Metab (Zhonghua Nei Fen Mi Dai Xie Za Zhi) 2007; 23(4): 291–293 (in Chinese)

    CAS  Google Scholar 

  6. Xu XS, Yang WT, Liu DY, Zhong J, Tian ZQ, Yan ZC, Ni YX, Chen J, Zhao ZG, Zhu ZM. Cardiovascular and Renal Damage in Hypertensive Complicated with Metabolic Disorders. Chin J Hypertens (Zhonghua Gao Xue Ya Za Zhi) 2006; 14(11): 894–898 (in Chinese)

    Google Scholar 

  7. Chu S, Zhu D, Xiong M. Linkage analysis of candidate genes for glucose and lipid metabolism with essential hypertension. Nation Med J China (Zhonghua Yi Xue Za Zhi) 2001; 81(1): 20–22 (in Chinese)

    CAS  Google Scholar 

  8. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999; 100(10): 1134–1146

    Article  PubMed  CAS  Google Scholar 

  9. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28(6): 1039–1049

    Article  PubMed  Google Scholar 

  10. Dang AM, Liu GZ. Uric acid and cardiovascular events. Chin J Cardiol (Zhonghua Xin Xue Guan Bing Za Zhi) 2003; 31(6): 478 (in Chinese)

    Google Scholar 

  11. Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005; 112(5): 666–673

    Article  PubMed  Google Scholar 

  12. Bonny A, Lacombe F, Yitemben M, Discazeaux B, Donetti J, Fahri P, Megbemado R, Estampes B. The 2007 ESH/ESC guidelines for the management of arterial hypertension. J Hypertens 2008; 26(4): 825, author reply 825–826

    Article  PubMed  CAS  Google Scholar 

  13. Gaciong Z, Symonides B. Hypertension 2010: what was new for the cardiologist? Expert Opin Pharmacother 2010; 11(16): 2579–2597

    Article  PubMed  CAS  Google Scholar 

  14. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001; 37(4): 1053–1059

    Article  PubMed  CAS  Google Scholar 

  15. Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther 2008; 88(11): 1322–1335

    Article  PubMed  Google Scholar 

  16. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67(5): 968–977

    Article  PubMed  CAS  Google Scholar 

  17. Fruchart JC, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche JM, Marx N, Plutzky J, Reiner Z, Rosenson RS, Staels B, Stock JK, Sy R, Wanner C, Zambon A, Zimmet P. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol 2008; 102(10 Suppl): 1K–34K

    Article  PubMed  Google Scholar 

  18. He HB, Zhao ZG, Pu YF, Chen J, Ni YX, Zhong J, Liu HY, Li YS, Yan ZC, Liu DY, Zhu ZM. Types of abdominal obesity and risks of metabolic syndrome. Nation Med J China (Zhonghua Yi Xue Za Zhi) 2008; 88(18): 1251–1254 (in Chinese)

    Google Scholar 

  19. Pu YF, He HB, Zhao ZG, Chen J, Ni YX, Zhong J, Liu HY, Yan ZC, Zhu ZM. Quantitative assessment of visceral fat in patients with abdominal obesity and its clinical significance. Nation Med J China (Zhonghua Yi Xue Za Zhi) 2008; 88(34): 2391–2394 (in Chinese)

    Google Scholar 

  20. Malik S, Wong ND. Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis. Expert Rev Cardiovasc Ther 2009; 7(3): 273–280

    Article  PubMed  Google Scholar 

  21. Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006; 47(6): 1093–1100

    Article  PubMed  CAS  Google Scholar 

  22. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358(9294): 1682–1686

    Article  PubMed  CAS  Google Scholar 

  23. Steyn K, Sliwa K, Hawken S, Commerford P, Onen C, Damasceno A, Ounpuu S, Yusuf S. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation 2005; 112(23): 3554–3561

    Article  PubMed  Google Scholar 

  24. Garnett SP, Baur LA, Srinivasan S, Lee JW, Cowell CT. Body mass index and waist circumference in midchildhood and adverse cardiovascular disease risk clustering in adolescence. Am J Clin Nutr 2007; 86(3): 549–555

    PubMed  CAS  Google Scholar 

  25. Zhu ZM. Obesity and cardiovascular disease — from epidemiology to pathogenesis. Chin J Diabete (Zhongguo Tang Niao Bing Za Zhi) 2006; 14(6): 402–404 (in Chinese)

    CAS  Google Scholar 

  26. Caballero AE. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res 2003; 11(11): 1278–1289

    Article  PubMed  CAS  Google Scholar 

  27. Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev 2006; 22(6): 423–436

    Article  PubMed  CAS  Google Scholar 

  28. Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 2009; 53(5 Suppl): S35–S42

    Article  PubMed  CAS  Google Scholar 

  29. Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld M. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care 2008; 31(Suppl 2): S155–160

    Article  PubMed  CAS  Google Scholar 

  30. Buyken AE, von Eckardstein A, Schulte H, Cullen P, Assmann G. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study. Eur J Cardiovasc Prev Rehabil 2007; 14(2): 230–236

    Article  PubMed  Google Scholar 

  31. Gao L, Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res 2009; 82(1): 9–20

    Article  PubMed  CAS  Google Scholar 

  32. Razani B, Chakravarthy MV, Semenkovich CF. Insulin resistance and atherosclerosis. Endocrinol Metab Clin North Am 2008; 37(3): 603–621, viii

    Article  PubMed  CAS  Google Scholar 

  33. Groop L. Genetics of the metabolic syndrome. Br J Nutr 2000; 83(Suppl 1): S39–S48

    PubMed  CAS  Google Scholar 

  34. Norris JM, Rich SS. Genetics of glucose homeostasis: implications for insulin resistance and metabolic syndrome. Arterioscler Thromb Vasc Biol 2012; 32(9): 2091–2096

    Article  PubMed  CAS  Google Scholar 

  35. Monda KL, North KE, Hunt SC, Rao DC, Province MA, Kraja AT. The genetics of obesity and the metabolic syndrome. Endocr Metab Immune Disord Drug Targets 2010; 10(2): 86–108

    Article  PubMed  CAS  Google Scholar 

  36. Chuang LM. Human genetics of the metabolic syndrome. Asia Pac J Clin Nutr 2008; 17(Suppl 1): 43–46

    PubMed  CAS  Google Scholar 

  37. Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 2011; 121(6): 2126–2132

    Article  PubMed  CAS  Google Scholar 

  38. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009; 58(8): 1091–1103

    Article  PubMed  CAS  Google Scholar 

  39. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH, DiDonato JA, Lusis AJ, Hazen SL. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472(7341): 57–63

    Article  PubMed  CAS  Google Scholar 

  40. Zhu ZM. Intervention of the critical component in metabolic syndrome: issues and challenges. Chin J Geriat Heart Brain Vessel Dis (Zhonghua Lao Nian Xin Nao Xue Guan Bing Za Zhi) 2009; 11(6): 401–403 (in Chinese)

    Google Scholar 

  41. Dominguez-Rodriguez A. Managing hypertension in cardiology practice: from individual risk factors and the metabolic syndrome to global cardiometabolic risk. Int J Clin Pract 2008; 62(9): 1303–1304

    Article  PubMed  CAS  Google Scholar 

  42. Zhu ZM. Should actively explore the comprehensive assessment of cardiometabolic risk. Chin J Cardiol (Zhonghua Xin Xue Guan Bing Za Zhi) 2007; 35(5): 387–389 (in Chinese)

    Google Scholar 

  43. Zhu ZM. Intensive glycemic control and cardiovascular events reduction: confusion and enlightenment. Chin J Diabete (Zhongguo Tang Niao Bing Za Zhi) 2009; 17(2): 85–87 (in Chinese)

    Google Scholar 

  44. Yang D, Luo Z, Ma S, Wong WT, Ma L, Zhong J, He H, Zhao Z, Cao T, Yan Z, Liu D, Arendshorst WJ, Huang Y, Tepel M, Zhu Z. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab 2010; 12(2): 130–141

    Article  PubMed  CAS  Google Scholar 

  45. Ma S, Yu H, Zhao Z, Luo Z, Chen J, Ni Y, Jin R, Ma L, Wang P, Zhu Z, Li L, Zhong J, Liu D, Nilius B, Zhu Z. Activation of the coldsensing TRPM8 channel triggers UCP1-dependent thermogenesis and prevents obesity. J Mol Cell Biol 2012; 4(2): 88–96

    Article  PubMed  CAS  Google Scholar 

  46. Zhang LL, Yan Liu D, Ma LQ, Luo ZD, Cao TB, Zhong J, Yan ZC, Wang LJ, Zhao ZG, Zhu SJ, Schrader M, Thilo F, Zhu ZM, Tepel M. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ Res 2007; 100(7): 1063–1070

    Article  PubMed  CAS  Google Scholar 

  47. Wang P, Yan Z, Zhong J, Chen J, Ni Y, Li L, Ma L, Zhao Z, Liu D, Zhu Z. Transient receptor potential vanilloid 1 activation enhances gut glucagon-like peptide-1 secretion and improves glucose homeostasis. Diabetes 2012; 61(8): 2155–2165

    Article  PubMed  CAS  Google Scholar 

  48. Zhu ZM. Concern about the particularity of the diagnosis and treatment of obesity-induced hypertension. Chin J Geriat Heart Brain Vessel Dis (Zhonghua Lao Nian Xin Nao Xue Guan Bing Za Zhi) 2008; 10(2): 85 (in Chinese)

    Google Scholar 

  49. Cooper-DeHoff RM, Pacanowski MA, Pepine CJ. Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum. J Am Coll Cardiol 2009; 53(5 Suppl): S28–S34

    Article  PubMed  CAS  Google Scholar 

  50. Shimabukuro M, Tanaka H, Shimabukuro T. Effects of telmisartan on fat distribution in individuals with the metabolic syndrome. J Hypertens 2007; 25(4): 841–848

    Article  PubMed  CAS  Google Scholar 

  51. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 2009; 32(1): 187–192

    Article  PubMed  Google Scholar 

  52. Bahadir O, Uzunlulu M, Oguz A, Bahadir MA. Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome. Hypertens Res 2007; 30(1): 49–53

    Article  PubMed  CAS  Google Scholar 

  53. He H, Zhao Z, Chen J, Ni Y, Zhong J, Yan Z, Li Y, Liu D, Pletcher MJ, Zhu Z. Metformin-based treatment for obesity-related hypertension: a randomized, double-blind, placebo-controlled trial. J Hypertens 2012; 30(7): 1430–1439

    Article  PubMed  CAS  Google Scholar 

  54. Ceriello A, Ihnat MA, Thorpe JE. Clinical review 2: The “metabolic memory”: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab 2009; 94(2): 410–415

    Article  PubMed  CAS  Google Scholar 

  55. Zhu ZM. Prevention and treatment strategies for diabetic macrovascular disease: from intensive glycemic control to coordination and balance. Chin J Endocrino Metab (Zhonghua Nei Fen Mi Dai Xie Za Zhi) 2009; 25(4): 361–365 (in Chinese)

    Google Scholar 

  56. Ashrafian H, le Roux CW, Darzi A, Athanasiou T. Effects of bariatric surgery on cardiovascular function. Circulation 2008; 118(20): 2091–2102

    Article  PubMed  Google Scholar 

  57. Demaria EJ, Winegar DA, Pate VW, Hutcher NE, Ponce J, Pories WJ. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg 2010; 252: 559–566; discussion 566–567

    PubMed  Google Scholar 

  58. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 2010; 61(1): 393–411

    Article  PubMed  CAS  Google Scholar 

  59. Reis CE, Alvarez-Leite JI, Bressan J, Alfenas RC. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index < 35 kg/m2: a literature review. Diabetes Technol Ther 2012; 14(4): 365–372

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Third Military Medical University, Chongqing Institute of Hypertension, Chongqing, 400042, China

    Zhiming Zhu & Peijian Wang

  2. Department of Cardiology, General Hospital of PLA Chengdu Military Area Command, Chengdu, 610083, China

    Shuangtao Ma

Authors
  1. Zhiming Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peijian Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shuangtao Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhiming Zhu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, Z., Wang, P. & Ma, S. Metabolic hypertension: concept and practice. Front. Med. 7, 201–206 (2013). https://doi.org/10.1007/s11684-013-0264-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-013-0264-4

Keywords

Search

Navigation